103 related articles for article (PubMed ID: 7794001)
1. [Refractory anemia with excess myeloblast in transformation induced remission by combined oral administration of cytarabine ocfosfate and 6-mercaptopurine].
Fukumi S; Mizorogi F; Matsuo A; Sato H; Abe T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):945-8. PubMed ID: 7794001
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
[TBL] [Abstract][Full Text] [Related]
3. [Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T].
Kadowaki I; Sasaki O; Sasaki T; Ishizawa K; Kimura J; Nomura J; Furuyama K; Harigae H; Shishido T; Okuda M
Gan To Kagaku Ryoho; 1995 Jan; 22(1):145-7. PubMed ID: 7529978
[No Abstract] [Full Text] [Related]
4. [Hypoplastic leukemia successfully treated by oral administration with cytarabine ocfosfate].
Okuyama Y; Kitazume K; Iwabe K; Usuki K; Urabe A
Rinsho Ketsueki; 1994 Jun; 35(6):593-7. PubMed ID: 8078195
[TBL] [Abstract][Full Text] [Related]
5. [A combination chemotherapy with cytarabine ocfosfate, low dose etoposide, and G-CSF for the treatment of high risk MDS (RAEB, RAEBt)--a pilot study].
Hara M; Kojima K; Azuma T; Narumi H; Shinagawa K
Rinsho Ketsueki; 1998 Apr; 39(4):314-6. PubMed ID: 9597900
[TBL] [Abstract][Full Text] [Related]
6. [Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate].
Nishi T; Funasako M; Hata N; Andoh K; Itoh Y; Ono H; Itoh K; Sato Y; Sato H; Taniji M; Nakai S; Ueda A; Fujimoto H; Ohata M
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1331-4. PubMed ID: 8831748
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M; Fujita N; Miyazaki S
Gan To Kagaku Ryoho; 1994 Mar; 21(4):535-8. PubMed ID: 8129396
[TBL] [Abstract][Full Text] [Related]
8. [Peripheral blood stem cell transfusion for a patient with RAEB-T].
Fujii H; Nakagawa H; Sonoda Y; Kuzuyama Y
Rinsho Ketsueki; 1993 Jun; 34(6):764-8. PubMed ID: 7690075
[TBL] [Abstract][Full Text] [Related]
9. [Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
Hamaoka R; Jozaki K; Amano T; Itoh H; Imai Y; Nishikawa M; Kurokawa M; Yonezawa T; Chinen Y
Gan To Kagaku Ryoho; 1995 May; 22(6):819-22. PubMed ID: 7755392
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide].
Kiyama Y; Suzuki G; Masauzi N; Ohizumi H; Kobayashi N; Ogasawara M; Naohara T; Saito M; Higa T; Kasai M
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1717-20. PubMed ID: 8886052
[TBL] [Abstract][Full Text] [Related]
11. [Therapy-related acute non-lymphocytic leukemia (M2) with 7;11 chromosome translocation induced into complete remission by low dose cytosine arabinoside and cytarabine ocfosfate therapy].
Shikoshi K; Shikoshi K; Niitsu N; Takada M; Umeda M
Nihon Ronen Igakkai Zasshi; 1994 Jun; 31(6):468-71. PubMed ID: 8078212
[TBL] [Abstract][Full Text] [Related]
12. [Intensive chemotherapy of refractory anemia with excess of blasts].
Dohy H; Kyo T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1223-8. PubMed ID: 3382197
[TBL] [Abstract][Full Text] [Related]
13. Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients.
Michels SD; Saumur J; Arthur DC; Robison LL; Brunning RD
Cancer; 1989 Dec; 64(11):2340-6. PubMed ID: 2804925
[TBL] [Abstract][Full Text] [Related]
14. [Successful induction chemotherapy for childhood RAEB-T with VP-16: a case report].
Tanizawa A; Sonomura T; Wakazono Y; Akiyama Y; Kubota M; Mikawa H
Rinsho Ketsueki; 1989 Jul; 30(7):1052-7. PubMed ID: 2810790
[TBL] [Abstract][Full Text] [Related]
15. [Successful emergency operation for massive hemorrhage due to jejunal angiodysplasia after intensive chemotherapy in a patient with refractory anemia with excess of blasts].
Morita K; Mizuno T; Itoh R; Suzuki H; Tanaka I
Rinsho Ketsueki; 1998 Jul; 39(7):526-31. PubMed ID: 9750461
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment of acute myelomonocytic leukemia developed from MDS with cytarabine ocfosfate (SPAC)].
Wake A; Takazawa A; Serino Y; Tonai S; Nakanishi M; Murakami S; Ogawa R; Nagata K; Mori N; Nakata K
Gan To Kagaku Ryoho; 1995 Feb; 22(3):395-8. PubMed ID: 7880111
[TBL] [Abstract][Full Text] [Related]
17. [Auer rods-positive neutrophils observed at diagnosis increased after remission induction in patient with acute promyelocytic leukemia].
Ashihara E; Ohkawa K; Gotoh H; Oku N; Inaba T; Murakami S; Itoh K; Fujita N; Shimazaki C; Nishio A
Rinsho Ketsueki; 1992 May; 33(5):666-70. PubMed ID: 1321302
[TBL] [Abstract][Full Text] [Related]
18. [A remarkable effect of K-18 (IgG-melphalan complex) in a case of RAEB with hypoplastic marrow].
Fujikawa K; Mogi Y; Ito K; Tsushima N; Saito T; Ishigaki S; Watanabe N; Kohgo Y; Mikami T; Niitsu Y
Gan To Kagaku Ryoho; 1991 Feb; 18(2):287-91. PubMed ID: 1992922
[TBL] [Abstract][Full Text] [Related]
19. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
[TBL] [Abstract][Full Text] [Related]
20. Results of aggressive chemotherapy for myelodysplastic syndromes.
Dohy H; Kyo T
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1428-34. PubMed ID: 3247817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
